| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/13/2007 | US7189848 Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation |
| 03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 03/13/2007 | US7189729 Methods and compositions as protein kinase inhibitors |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/08/2007 | WO2007026920A2 Amide derivatives as rock inhibitors |
| 03/08/2007 | WO2007025901A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025900A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| 03/08/2007 | WO2007025899A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025898A1 Process for synthesis of aryloxy diaminopyrimidines |
| 03/08/2007 | WO2007025776A2 Cysteine protease inhibitors |
| 03/08/2007 | US20070054929 2-Substituted pyrimidines |
| 03/08/2007 | US20070054918 N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/08/2007 | US20070054894 Quinazoline potassium channel inhibitors |
| 03/08/2007 | US20070051944 Organic electroluminescent element |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620129A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2620033A1 Process for synthesis of aryloxy diaminopyrimidines |
| 03/08/2007 | CA2619919A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619898A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/07/2007 | EP1759713A2 Lock and key micelles |
| 03/07/2007 | EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 03/07/2007 | EP1758871A1 Pyrazolo pyrimidines |
| 03/07/2007 | EP1758870A1 4-phenyl-pyrimidine-2-carbonitrile derivatives |
| 03/07/2007 | EP1758865A1 Pyridine analogs as c5a antagonists |
| 03/07/2007 | EP1758859A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | EP1685131B1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1925862A Treatment of diseases associated with the EGR-1 enhancer element |
| 03/07/2007 | CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1303080C Nolatrexed hydrochloride synthesis process |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 03/06/2007 | US7186834 Substituted iminoazines |
| 03/06/2007 | US7186830 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 03/06/2007 | US7186828 Cyclic urea compounds and preparation thereof |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/06/2007 | CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007024922A1 Immunosuppressant compounds and compositions |
| 03/01/2007 | WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 03/01/2007 | WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 03/01/2007 | WO2007023073A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 03/01/2007 | WO2007022964A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 03/01/2007 | WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2006124748A3 Multicyclic compounds and methods of their use |
| 03/01/2007 | WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof |
| 03/01/2007 | WO2006098969A3 Quinazolinone t-type calcium channel antagonists |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049758 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 03/01/2007 | US20070049757 Methods for the synthesis of substituted amino uracils |
| 03/01/2007 | US20070049755 Novel triazolo pyrimidine compounds |
| 03/01/2007 | US20070049751 5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine; using iodine monchloride for iodination, cyanoalkylation, hdyrogenation, cyclization; chemical intermediates; using guanidine carbonate, Brederick's reagent and aniline reagent |
| 03/01/2007 | US20070049610 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049534 Urinary track diseases; analgesics; antiinflammatory agents; gastrointestinal disorders; premenstrual tension; respiratory system disorders; incotinence |
| 03/01/2007 | CA2619366A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases |
| 03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
| 03/01/2007 | CA2619037A1 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1757593A1 Therapeutic agent for nonviral hepatitis |
| 02/28/2007 | EP1756113A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756062A1 Compounds and compositions as ppar modulators |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756041A2 Polycationic compounds and uses thereof |
| 02/28/2007 | EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles |
| 02/28/2007 | EP1755607A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 02/28/2007 | EP1755606A1 Quinazolinone derivatives useful as vanilloid antagonists |
| 02/28/2007 | EP1622880B1 Substituted dihydrochinazolines having antiviral properties |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1919846A Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 02/28/2007 | CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 02/28/2007 | CN1301992C Pyrazolyl pyrimidines |
| 02/28/2007 | CN1301978C Preparation of 2-methyl-4-pyrimidone |
| 02/28/2007 | CN1301977C Preparation of aminopyrimidine compounds |
| 02/28/2007 | CN1301976C Synthesis of chlorinated pyrimidines |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183287 Substituted pyrimidinones |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/22/2007 | WO2007022488A2 Crystalline rosuvastatin intermediate |